[Form 4] Apogee Enterprises Inc Insider Trading Activity

Rhea-AI Filing Summary

Apogee Enterprises Director Patricia K. Wagner reported significant insider transactions on June 25, 2025. Key details include:

• Acquired 2,954 shares of Common Stock at $0 as restricted stock awards
• Shares vest over three years with one-third vesting annually
• Following the transaction, Wagner directly owns 21,471 shares
• Additionally holds 6,106 shares indirectly through a Family Trust

The transaction was executed under the 2019 Non-Employee Director Stock Plan. The indirect holdings are managed through a revocable living trust benefiting Wagner, spouse, and minor children as contingent beneficiaries. The Form 4 was filed by attorney-in-fact Meghan M. Elliott on June 27, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wagner Patricia K

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MN 55435

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/25/2025		A		2,954(1)	A	$0	21,471(2)	D
Common Stock								6,106(3)	I	Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares vest over a three year vesting period with one-third of the shares vesting on each anniversary of the award.

2. Includes restricted stock awards under the 2019 Non-Employee Director Stock Plan.

3. The reporting person gifted these shares to a revocable living trust for the benefit of himself and his spouse, with their minor children as contingent beneficiaries. The reporting person and his spouse are the co-trustees of the trust.

Remarks:

	/s/ Meghan M. Elliott, Attorney-in-Fact for Patricia K. Wagner	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of APOG stock did Patricia Wagner acquire on June 25, 2025?

Patricia Wagner acquired 2,954 shares of APOG common stock on June 25, 2025 as a restricted stock award. These shares vest over a three-year period, with one-third vesting on each anniversary of the award.

What is Patricia Wagner's total direct ownership of APOG stock after the June 2025 transaction?

Following the reported transaction, Patricia Wagner directly owns 21,471 shares of APOG stock, which includes restricted stock awards under the 2019 Non-Employee Director Stock Plan.

How many APOG shares does Patricia Wagner hold indirectly through a family trust?

Patricia Wagner indirectly owns 6,106 shares of APOG stock through a revocable living trust, which benefits herself and her spouse, with their minor children as contingent beneficiaries. She and her spouse serve as co-trustees of the trust.

What is Patricia Wagner's role at APOG as disclosed in the Form 4?

According to the Form 4 filing, Patricia K. Wagner serves as a Director of Apogee Enterprises, Inc. (APOG), as indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.

What was the purchase price for APOG shares acquired by Patricia Wagner in June 2025?

The shares were awarded to Patricia Wagner at a price of $0, as indicated in the transaction details of the Form 4 filing. This appears to be a stock grant as part of director compensation rather than a market purchase.